Security key
52187K101
- Security type / class
- Equity / COM
- Total 13F shares
- 37,588,856
- Total 13F value
- $43,231,309
- Share change
- -5,421,502
- Put/Call ratio
- 24%
- SEC-reported price per share
- $1.15
- Number of holders
- 66
- Value change
- -$8,691,212
- Number of buys
- 24
- Number of sells
- 32
Open additional details 1 more signal available
Report period
Q2 2022
Institutions
66
Top holders
10
LPTX full security history
Ownership snapshot
Full 13F holder table
CYPHERPUNK TECHNOLOGIES INC. SEC filings
CYPHERPUNK TECHNOLOGIES INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of LPTX - LEAP THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BeOne Medicines Ltd.
Disclosed value leader
BeOne Medicines Ltd.
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5
13F
Highest disclosed value: $20,943,045
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BeOne Medicines Ltd. has the largest disclosed position value at $20.94M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BeOne Medicines Ltd.'s linked filing trail.
Disclosed position value
Top 5
BeOne Medicines Ltd.
$20.94M
PERCEPTIVE ADVISORS LLC
$13.92M
Artal Group S.A.
$7M
Rock Springs Capital Management LP
$6.29M
VANGUARD GROUP INC
$5.7M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$20,943,045
7,348,437 shares
|
— | 24 Sep 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$13,915,000
7,951,448 shares
|
— | 31 Mar 2022 |
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$7,000,000
4,000,000 shares
|
— | 31 Mar 2022 |
| Rock Springs Capital Management LP |
13F
Company
|
—
denominator unverified
|
$6,292,000
3,595,447 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$5,699,000
3,256,331 shares
|
— | 31 Mar 2022 |
| M28 Capital Management LP |
13F
Company
|
—
denominator unverified
|
$4,663,000
2,664,400 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
37,588,856
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
78
Q2 2022 holders
66
Holder diff
-12
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|